- Home
- EUDA vs ESLA Comparison
EUDA vs ESLA Comparison
Compare EUDA & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EUDA | ESLA |
|---|---|---|
| Founded | 2021 | 2021 |
| Country | Singapore | United States |
| Employees | 123 | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8M | 45.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EUDA | ESLA |
|---|---|---|
| Price | $15.80 | $0.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $55.00 | $8.00 |
| AVG Volume (30 Days) | 3.0K | ★ 34.3K |
| Earning Date | 12-19-2023 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $134.73 | N/A |
| Revenue Next Year | $195.03 | N/A |
| P/E Ratio | $123.62 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $0.78 |
| 52 Week High | $25.70 | $3.15 |
Technical Indicators
Market Signals| Indicator | EUDA | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 52.63 | 31.92 |
| Support Level | $2.07 | N/A |
| Resistance Level | $18.90 | $1.31 |
| Average True Range (ATR) | 0.57 | 0.10 |
| MACD | -0.38 | -0.00 |
| Stochastic Oscillator | 21.22 | 0.00 |
Price Performance
Historical ComparisonAbout EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.